201 related articles for article (PubMed ID: 30536342)
21. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease.
Nishikimi T; Futoo Y; Tamano K; Takahashi M; Suzuki T; Minami J; Honda T; Uetake S; Asakawa H; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
Am J Kidney Dis; 2001 Jun; 37(6):1201-8. PubMed ID: 11382689
[TBL] [Abstract][Full Text] [Related]
22. Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease.
Osajima A; Okazaki M; Tamura M; Anai H; Kabashima N; Suda T; Iwamoto M; Ota T; Watanabe Y; Kanegae K; Nakashima Y
Nephron; 2002 Dec; 92(4):832-9. PubMed ID: 12399629
[TBL] [Abstract][Full Text] [Related]
23. Predictors of B-type natriuretic peptide and left atrial volume index in patients with preserved left ventricular systolic function: an echocardiographic-catheterization study.
Jaubert MP; Armero S; Bonello L; Nicoud A; Sbragia P; Paganelli F; Arques S
Arch Cardiovasc Dis; 2010 Jan; 103(1):3-9. PubMed ID: 20142114
[TBL] [Abstract][Full Text] [Related]
24. The evaluation of the clinical utility of urocortin 1 and adrenomedullin versus proBNP in systolic heart failure.
Yıldırım E; Cengiz M; Yıldırım N; Aslan K; İpek E; Korkmaz AF; Ulusoy FR; Hatem E
Anatol J Cardiol; 2017 Mar; 17(3):184-190. PubMed ID: 25868038
[TBL] [Abstract][Full Text] [Related]
25. Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension.
Cases A; Esforzado N; Lario S; Vera M; Lopez-Pedret J; Rivera-Fillat F; Jimenez W
Kidney Int; 2000 Feb; 57(2):664-70. PubMed ID: 10652045
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
[TBL] [Abstract][Full Text] [Related]
27. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
Cataliotti A; Malatino LS; Jougasaki M; Zoccali C; Castellino P; Giacone G; Bellanuova I; Tripepi R; Seminara G; Parlongo S; Stancanelli B; Bonanno G; Fatuzzo P; Rapisarda F; Belluardo P; Signorelli SS; Heublein DM; Lainchbury JG; Leskinen HK; Bailey KR; Redfield MM; Burnett JC
Mayo Clin Proc; 2001 Nov; 76(11):1111-9. PubMed ID: 11702899
[TBL] [Abstract][Full Text] [Related]
28. The relationship between B-type natriuretic peptide levels and echocardiographic parameters in patients with heart failure admitted to the emergency department.
Karakiliç E; Kepez A; Abali G; Coşkun F; Kunt M; Tokgözoğlu L
Anadolu Kardiyol Derg; 2010 Apr; 10(2):143-9. PubMed ID: 20382614
[TBL] [Abstract][Full Text] [Related]
29. The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease.
Sheen V; Bhalla V; Tulua-Tata A; Bhalla MA; Weiss D; Chiu A; Abdeen O; Mullaney S; Maisel A
Am Heart J; 2007 Feb; 153(2):244.e1-5. PubMed ID: 17239684
[TBL] [Abstract][Full Text] [Related]
30. The prognostic role of brain natriuretic peptides in hemodialysis patients.
Naganuma T; Sugimura K; Wada S; Yasumoto R; Sugimura T; Masuda C; Uchida J; Nakatani T
Am J Nephrol; 2002; 22(5-6):437-44. PubMed ID: 12381941
[TBL] [Abstract][Full Text] [Related]
31. Assessment of factors affecting plasma BNP levels in patients with chronic atrial fibrillation and preserved left ventricular systolic function.
Kim BJ; Hwang SJ; Sung KC; Kim BS; Kang JH; Lee MH; Park JR
Int J Cardiol; 2007 May; 118(2):145-50. PubMed ID: 16959341
[TBL] [Abstract][Full Text] [Related]
32. CA 125 levels and left ventricular function in patients with end-stage renal disease on maintenance hemodialysis.
Yilmaz H; Gürel OM; Celik HT; Sahiner E; Yildirim ME; Bilgiç MA; Bavbek N; Akcay A
Ren Fail; 2014 Mar; 36(2):210-6. PubMed ID: 24289262
[TBL] [Abstract][Full Text] [Related]
33. [Study on the clinical significance of plasma adrenomedullin and brain natriuretic polypeptide in the patients with chronic cor pulmonale on highland].
Yang SY; Feng EZ; Shen JL; Xu J; Zhao LH; Wu XM
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Jun; 17(6):361-3. PubMed ID: 15970104
[TBL] [Abstract][Full Text] [Related]
34. [Relationship between B-type natriuretic peptide plasma level and left ventricular function in patients with chronic kidney disease on different type of treatment].
Rasić S; Hadzovic-Dzuvo A; Rebić D; Dzemidzić J; Bilal F; Mataradzija A
Acta Med Croatica; 2008; 62 Suppl 1():7-11. PubMed ID: 18578326
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of N-terminal-pro B-type natriuretic peptide as a diagnostic marker for left ventricular dysfunction in children with end-stage renal disease on hemodialysis.
Zoair AM; Abdel-Hafez MA; Mawlana W; Sweylam MA
Saudi J Kidney Dis Transpl; 2016; 27(6):1114-1122. PubMed ID: 27900955
[TBL] [Abstract][Full Text] [Related]
36. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis.
Nitta K; Kawashima A; Yumura W; Naruse M; Oba T; Kabaya T; Nihei H
Am J Nephrol; 1998; 18(5):411-5. PubMed ID: 9730565
[TBL] [Abstract][Full Text] [Related]
37. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.
Haug C; Metzele A; Steffgen J; Kochs M; Hombach V; Grünert A
Clin Investig; 1994 Jun; 72(6):430-4. PubMed ID: 7950153
[TBL] [Abstract][Full Text] [Related]
38. Bioactivity and interactions of adrenomedullin and brain natriuretic peptide in patients with heart failure.
Lainchbury JG; Nicholls MG; Espiner EA; Yandle TG; Lewis LK; Richards AM
Hypertension; 1999 Jul; 34(1):70-5. PubMed ID: 10406826
[TBL] [Abstract][Full Text] [Related]
39. Left ventricular torsional dynamics in aortic stenosis: relationship between left ventricular untwisting and filling pressures. A two-dimensional speckle tracking study.
Popescu BA; Calin A; Beladan CC; Muraru D; Rosca M; Deleanu D; Lancellotti P; Antonini-Canterin F; Nicolosi GL; Ginghina C
Eur J Echocardiogr; 2010 Jun; 11(5):406-13. PubMed ID: 20053657
[TBL] [Abstract][Full Text] [Related]
40. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function.
Troughton RW; Prior DL; Pereira JJ; Martin M; Fogarty A; Morehead A; Yandle TG; Richards AM; Starling RC; Young JB; Thomas JD; Klein AL
J Am Coll Cardiol; 2004 Feb; 43(3):416-22. PubMed ID: 15013124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
